Macrogen, Inc. (KOSDAQ:038290)
16,840
+100 (0.60%)
Dec 10, 2025, 3:30 PM KST
Macrogen Market Cap
Macrogen has a market cap or net worth of 181.49 billion as of December 10, 2025. Its market cap has increased by 14.60% in one year.
Market Cap
181.49B
Enterprise Value
258.27B
Revenue
179.98B
Ranking
n/a
PE Ratio
n/a
Stock Price
16,840.00
Market Cap Chart
Since September 14, 2000, Macrogen's market cap has increased from 148.29B to 181.49B, an increase of 22.39%. That is a compound annual growth rate of 0.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 181.49B | 10.36% |
| Dec 30, 2024 | 164.45B | -21.52% |
| Dec 28, 2023 | 209.56B | 8.16% |
| Dec 29, 2022 | 193.74B | -33.59% |
| Dec 30, 2021 | 291.72B | 9.42% |
| Dec 30, 2020 | 266.61B | 7.29% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.41T |
| Celltrion | 40.94T |
| ALTEOGEN | 24.49T |
| ABL Bio | 10.51T |
| SK Biopharmaceuticals | 10.44T |
| Yuhan | 8.66T |
| LigaChem Biosciences | 6.75T |
| HLB Co., Ltd. | 6.53T |